Development
Tharimmune, Inc.
THAR
$1.51
-$0.0001-0.01%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 28.07% | 48.53% | 107.27% | 184.54% | 237.17% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 37.39% | 66.57% | 147.13% | 166.70% | 114.53% |
| Operating Income | -37.39% | -66.57% | -147.13% | -166.70% | -114.53% |
| Income Before Tax | -9.98% | -102.44% | -199.32% | -183.52% | -283.98% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9.98% | -102.44% | -199.32% | -183.52% | -283.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9.98% | -102.44% | -199.32% | -183.52% | -283.98% |
| EBIT | -37.39% | -66.57% | -147.13% | -166.70% | -114.53% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 30.88% | -196.91% | -332.79% | -162.56% | -118.23% |
| Normalized Basic EPS | 30.88% | 1.89% | -21.56% | -8.07% | -19.22% |
| EPS Diluted | 30.88% | -196.91% | -332.79% | -162.56% | -118.23% |
| Normalized Diluted EPS | 30.88% | 1.89% | -21.56% | -8.07% | -19.22% |
| Average Basic Shares Outstanding | 188.65% | 38.08% | 42.05% | 55.65% | 77.76% |
| Average Diluted Shares Outstanding | 188.65% | 38.08% | 42.05% | 55.65% | 77.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |